|
業務類別
|
-- |
|
業務概覽
|
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities. |
| 公司地址
| 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088 |
| 電話號碼
| +81 338173030 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.eisai.co.jp |
| 員工數量
| 10917 |
| Mr. Haruo Naito |
Director, Corporate Officer and Chief Executive Officer |
-- |
12/06/2026 |
|
|
| Mr. Fumihiko Ike |
Chairman of the Board |
12/06/2026 |
| Mr. Hiroyuki Kato |
Director |
12/06/2026 |
| Ms. Yuko Yasuda |
Independent Director |
12/06/2026 |
| Mr. Koichi Kawana |
Independent Director |
12/06/2026 |
| Ms. Ryoko Ueda |
Independent Director |
12/06/2026 |
| Mr. Ryota Miura |
Independent Director |
12/06/2026 |
| Mr. Haruo Naito |
Director, Corporate Officer and Chief Executive Officer |
12/06/2026 |
| Mr. Richard Thornley |
Independent Director |
12/06/2026 |
| Mr. Toru Moriyama |
Independent Director |
12/06/2026 |
| Ms. Yuko Toyoda |
Independent Director |
12/06/2026 |
| Mr. Takuji Kanai |
Independent Director |
12/06/2026 |
| Mr. Kenta Takahashi |
Director |
12/06/2026 |
|
|
|
|
